Serina Therapeutics Inc. (SER)

5.42

0.13 (2.46%)

At close: Mar 31, 2025, 3:58 PM

6.00

10.70%

After-hours: Mar 31, 2025, 05:45 PM EDT

Serina Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-11.21M	-14.8M	-2.68M	-1.26M	-10.39M	-12.15M	-7.5M	-6.58M	-15.49M
Depreciation & Amortization	194K	131K	61.27K	33.37K	1.25M	951K	535K	682K	845K
Stock-Based Compensation	2.6M	25K	7.11K	82.94K	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-1.72M	625K	153.5K	-1.61M	-612K	-347K	-413K	187K	124K
Other Non-Cash Items	-5.4M	6.22M	148.25K	-122.21K	3.74M	3.42M	-793K	-388K	5.42M
Deferred Income Tax	n/a	n/a	401.79K	-225.38K	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-3.32M	625K	-11.94K	-754.79K	-260K	-410K	211K	776K	1.31M
Operating Cash Flow	-17.14M	-7.8M	-2.08M	-2.25M	-7.82M	-10.16M	-8M	-6.29M	-8.43M
Capital Expenditures	-22K	n/a	-9.68K	-108.43K	-20K	-641K	-1.89M	-1K	-23K
Acquisitions	n/a	n/a	n/a	466K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-666K	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	990.62K	931.75K	n/a	354K	3.21M	n/a	n/a
Other Investing Acitivies	n/a	-10M	n/a	200K	n/a	-74K	5K	6K	-5K
Investing Cash Flow	-22K	-10M	980.94K	823.32K	-20K	-361K	1.33M	5K	-28K
Debt Repayment	2.88M	10.05M	1.31M	-12.91K	n/a	1.76M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.34M	7.45M	n/a	1.09M	5.96M	n/a	n/a	1.3M	4.81M
Financial Cash Flow	13.21M	17.5M	1.31M	1.08M	5.96M	6.26M	6M	13.28M	7.25M
Net Cash Flow	-3.95M	-300K	217.38K	-350.21K	-1.82M	-4.36M	-668K	7.12M	-1.2M
Free Cash Flow	-17.16M	-7.8M	-2.09M	-2.36M	-7.84M	-10.8M	-9.89M	-6.29M	-8.45M